A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Titel:
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Auteur:
Yam, Clinton Mittendorf, Elizabeth A. Garber, Haven R. Sun, Ryan Damodaran, Senthil Murthy, Rashmi K. Ramirez, David Karuturi, Meghan Layman, Rachel M. Ibrahim, Nuhad Rauch, Gaiane M. Adrada, Beatriz E. Candelaria, Rosalind P. White, Jason B. Ravenberg, Elizabeth Clayborn, Alyson Ding, Qing Qing Symmans, W. Fraser Prabhakaran, Sabitha Thompson, Alastair M. Valero, Vicente Tripathy, Debu Huo, Lei Moulder, Stacy L. Litton, Jennifer K.